SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001070081-21-000017
Filing Date
2021-05-04
Accepted
2021-05-04 16:36:44
Documents
85
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptct-20210331x10q.htm   iXBRL 10-Q 2023087
2 EX-10.1 ptct-20210331ex101cf1a77.htm EX-10.1 18888
3 EX-31.1 ptct-20210331ex31128499b.htm EX-31.1 10918
4 EX-31.2 ptct-20210331ex312c36715.htm EX-31.2 10720
5 EX-32.1 ptct-20210331ex321c97942.htm EX-32.1 5930
6 EX-32.2 ptct-20210331ex3228cfd43.htm EX-32.2 6116
  Complete submission text file 0001070081-21-000017.txt   10636778

Data Files

Seq Description Document Type Size
7 EX-101.SCH ptct-20210331.xsd EX-101.SCH 68727
8 EX-101.CAL ptct-20210331_cal.xml EX-101.CAL 81698
9 EX-101.DEF ptct-20210331_def.xml EX-101.DEF 333675
10 EX-101.LAB ptct-20210331_lab.xml EX-101.LAB 693985
11 EX-101.PRE ptct-20210331_pre.xml EX-101.PRE 571756
12 EXTRACTED XBRL INSTANCE DOCUMENT ptct-20210331x10q_htm.xml XML 2192575
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 21889144
SIC: 2834 Pharmaceutical Preparations